Mild-to-Moderate Hypertriglyceridemia Leads to Acute Pancreatitis
By LabMedica International staff writers Posted on 23 Nov 2016 |

Image: A histopathology of acute pancreatitis showing hemorrhage, parenchymal necrosis, and fat necrosis (Photo courtesy of Kathryn Lindsey, MD).
Pancreatitis is very painful and it may lead to fatalities and until now, medical science has connected the risk of developing this illness to gallstone, a high intake of alcohol and very high concentrations of blood fats or triglycerides.
Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.
Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.
The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.
Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.
Related Links:
Copenhagen University Hospital
Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.
Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.
The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.
Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.
Related Links:
Copenhagen University Hospital
Latest Clinical Chem. News
- ‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
- Low-Cost Portable Screening Test to Transform Kidney Disease Detection
- New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Channels
Molecular Diagnostics
view channel
Cheap Cell-Free DNA Based Test Accurately Predicts Preterm Birth
Preterm birth (PTB) occurs in around 11% of all births globally, leading to considerable morbidity and mortality for both mothers and their newborns. Identifying pregnancies at risk of PTB early in gestation... Read more
RNA Blood Test Detects Cancers and Resistance to Treatment
A newly developed blood test offers the ability to detect cancer, understand how cancer resists treatments, and assess tissue damage from non-cancerous conditions. This innovative test, created by researchers... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channelBreakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying TB, preventing its spread, and ultimately working towards its eradication. TB can remain dormant in the body for... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more